Cognitive Effects of Antiepileptic Treatment

Antiepileptic drugs (AEDs) are prescribed to prevent or reduce the frequency of seizures, yet their use can be accompanied by a range of cognitive side effects. These effects span multiple domains including memory, attention, processing speed and executive function. Sedative properties of some agents may lead to bradyphrenia and reduced alertness, while others can impair verbal fluency or visual–spatial skills. Polytherapy regimens, in which two or more AEDs are combined, often exacerbate cognitive burden compared with monotherapy. Vulnerability varies with age, comorbidity and baseline cognitive reserve, making older adults and children particularly susceptible. Mechanisms underlying these impairments include direct pharmacodynamic modulation of neurotransmitter systems, adverse effects on synaptic plasticity and network connectivity, and interactions with concurrent medications. Clinicians must weigh seizure control against potential cognitive trade-offs, integrating regular neuropsychological assessment into treatment planning. Emerging predictive tools and biomarkers aim to personalise drug selection and dosing to minimise cognitive sequelae while maintaining efficacy, thereby improving quality of life and functional outcomes on a global scale.

Research from Nature Portfolio

Recent studies have harnessed machine-learning algorithms to predict which outpatients with epilepsy are most at risk of cognitive decline following antiepileptic treatment. By analysing demographic and clinical features—such as age at onset, seizure frequency, MRI abnormalities and EEG discharge patterns—random forest models achieved high accuracy in forecasting performance on screening instruments. These predictive frameworks offer objective support for selecting monotherapy or adjusting dosages to reduce cognitive side effects. Work in this area underscores the feasibility of combining routine clinical data with algorithmic approaches to guide personalised therapy and pre-empt cognitive impairment in diverse clinical settings.

Cognitive Effects of Antiepileptic Treatment publication trend

The graph below shows the total number of articles in cognitive effects of antiepileptic treatment across all publications each year (not limited to Nature Index journals).

Technical terms

Antiepileptic drug (AED): A medication used to prevent or control epileptic seizures by modulating neuronal excitability.

Monotherapy: Treatment with a single pharmacological agent.

Polytherapy: Concurrent use of two or more pharmacological agents, often to achieve superior seizure control but with increased risk of adverse effects.

Executive function: Higher-order cognitive processes including planning, cognitive flexibility and inhibitory control.

Functional connectivity: The statistical association between activity in distinct brain regions, often measured by EEG or fMRI.

Biomarker: A measurable indicator of a physiological state or condition, used here to predict risk of cognitive impairment.

References

1. Factors for cognitive impairment in adult epileptic patients. Brain and Behavior (2019).
2. The association of gabapentin initiation and neurocognitive changes in older adults with normal cognition. Frontiers in Pharmacology (2022).
3. Predicting cognitive impairment in outpatients with epilepsy using machine learning techniques. Scientific Reports (2021).